BridgeBio Pharma Net Worth 2018-2024 | BBIO
Interactive chart of historical net worth (market cap) for BridgeBio Pharma (BBIO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. BridgeBio Pharma net worth as of November 01, 2024 is $4.79B.
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$4.791B |
$0.009B |
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
|